Global Gastrointestinal OTC Drugs Market 2023-2027

Description

List of Tables

The gastrointestinal OTC drugs market is forecasted to grow by USD 4759.86 mn during 2022-2027, accelerating at a CAGR of 5.29% during the forecast period. The report on the gastrointestinal OTC drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the prevalence of gastrointestinal disorders, a rise in adoption of gastrointestinal OTC drugs due to easy availability and affordability, and the availability of multiple payment options.

Technavio's gastrointestinal OTC drugs market is segmented as below:

By Product

Antacid
Laxatives
Anti-diarrheal
Anti-emetics
Others

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in the adoption of online platforms for gastrointestinal OTC drugs as one of the prime reasons driving the gastrointestinal OTC drugs market growth during the next few years. Also, an increase in the number of drug approvals and a shift by pharmaceutical companies from prescription to gastrointestinal OTC drugs will lead to sizable demand in the market.

The report on the gastrointestinal OTC drugs market covers the following areas:

Gastrointestinal OTC drugs market sizing
Gastrointestinal OTC drugs market forecast
Gastrointestinal OTC drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal OTC drugs market vendors that include Abbott Laboratories, AbbVie Inc., Bausch Health Co. Inc., Bayer AG, Cipla Ltd., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., Zoic Pharmaceuticals Pvt. Ltd., and Boehringer Ingelheim International GmbH. Also, the gastrointestinal otc drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75270

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global gastrointestinal OTC drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global gastrointestinal otc drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antacid - Market size and forecast 2022-2027
Exhibit 34: Chart on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antacid - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antacid - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antacid - Year-over-year growth 2022-2027 (%)
6.4 Laxatives - Market size and forecast 2022-2027
Exhibit 38: Chart on Laxatives - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Laxatives - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Laxatives - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Laxatives - Year-over-year growth 2022-2027 (%)
6.5 Anti-diarrheal - Market size and forecast 2022-2027
Exhibit 42: Chart on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Anti-diarrheal - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Anti-diarrheal - Year-over-year growth 2022-2027 (%)
6.6 Anti-emetics - Market size and forecast 2022-2027
Exhibit 46: Chart on Anti-emetics - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Anti-emetics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Anti-emetics - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Anti-emetics - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ million)
Exhibit 55: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 56: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 57: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 58: Chart on Comparison by Distribution Channel
Exhibit 59: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 60: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 64: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 68: Market opportunity by Distribution Channel ($ million)
Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key news
Exhibit 122: Abbott Laboratories - Key offerings
Exhibit 123: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 124: AbbVie Inc. - Overview
Exhibit 125: AbbVie Inc. - Product / Service
Exhibit 126: AbbVie Inc. - Key news
Exhibit 127: AbbVie Inc. - Key offerings
12.5 Bausch Health Co. Inc.
Exhibit 128: Bausch Health Co. Inc. - Overview
Exhibit 129: Bausch Health Co. Inc. - Business segments
Exhibit 130: Bausch Health Co. Inc. - Key news
Exhibit 131: Bausch Health Co. Inc. - Key offerings
Exhibit 132: Bausch Health Co. Inc. - Segment focus
12.6 Bayer AG
Exhibit 133: Bayer AG - Overview
Exhibit 134: Bayer AG - Business segments
Exhibit 135: Bayer AG - Key news
Exhibit 136: Bayer AG - Key offerings
Exhibit 137: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 138: Boehringer Ingelheim International GmbH - Overview
Exhibit 139: Boehringer Ingelheim International GmbH - Business segments
Exhibit 140: Boehringer Ingelheim International GmbH - Key news
Exhibit 141: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 142: Boehringer Ingelheim International GmbH - Segment focus
12.8 Cipla Ltd.
Exhibit 143: Cipla Ltd. - Overview
Exhibit 144: Cipla Ltd. - Business segments
Exhibit 145: Cipla Ltd. - Key news
Exhibit 146: Cipla Ltd. - Key offerings
Exhibit 147: Cipla Ltd. - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 148: Dr Reddys Laboratories Ltd. - Overview
Exhibit 149: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 150: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 151: Dr Reddys Laboratories Ltd. - Segment focus
12.10 GlaxoSmithKline Plc
Exhibit 152: GlaxoSmithKline Plc - Overview
Exhibit 153: GlaxoSmithKline Plc - Business segments
Exhibit 154: GlaxoSmithKline Plc - Key news
Exhibit 155: GlaxoSmithKline Plc - Key offerings
Exhibit 156: GlaxoSmithKline Plc - Segment focus
12.11 Haleon Plc
Exhibit 157: Haleon Plc - Overview
Exhibit 158: Haleon Plc - Business segments
Exhibit 159: Haleon Plc - Key offerings
Exhibit 160: Haleon Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Exhibit 161: Johnson and Johnson Services Inc. - Overview
Exhibit 162: Johnson and Johnson Services Inc. - Business segments
Exhibit 163: Johnson and Johnson Services Inc. - Key news
Exhibit 164: Johnson and Johnson Services Inc. - Key offerings
Exhibit 165: Johnson and Johnson Services Inc. - Segment focus
12.13 Novartis AG
Exhibit 166: Novartis AG - Overview
Exhibit 167: Novartis AG - Business segments
Exhibit 168: Novartis AG - Key offerings
Exhibit 169: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 170: Pfizer Inc. - Overview
Exhibit 171: Pfizer Inc. - Product / Service
Exhibit 172: Pfizer Inc. - Key news
Exhibit 173: Pfizer Inc. - Key offerings
12.15 Prestige Consumer Healthcare Inc.
Exhibit 174: Prestige Consumer Healthcare Inc. - Overview
Exhibit 175: Prestige Consumer Healthcare Inc. - Business segments
Exhibit 176: Prestige Consumer Healthcare Inc. - Key offerings
Exhibit 177: Prestige Consumer Healthcare Inc. - Segment focus
12.16 Sanofi SA
Exhibit 178: Sanofi SA - Overview
Exhibit 179: Sanofi SA - Business segments
Exhibit 180: Sanofi SA - Key news
Exhibit 181: Sanofi SA - Key offerings
Exhibit 182: Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 184: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 185: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 186: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 187: Inclusions checklist
Exhibit 188: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 189: Currency conversion rates for US$
13.4 Research methodology
Exhibit 190: Research methodology
Exhibit 191: Validation techniques employed for market sizing
Exhibit 192: Information sources
13.5 List of abbreviations
Exhibit 193: List of abbreviations